Skip to main content

Table 2 Most common integument-related toxicities (any grade; incidence ≥10% in the overall group)

From: Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

 

n(%)

WT KRAS(n = 86)

MT KRAS(n = 59)

Overall (n = 154)

Any grade

Grade ≥3

Any grade

Grade ≥3

Any grade

Grade ≥3

Any integument-related AE

84 (98)

29 (34)

58 (98)

22 (37)

151 (98)

55 (36)

Rash

37 (43)

7 (8)

21 (26)

6 (10)

64 (42)

15 (10)

Dry skin

39 (45)

0 (0)

21 (36)

1 (2)

61 (40)

1 (1)

Acne

29 (34)

6 (7)

22 (37)

8 (14)

55 (36)

15 (10)

Alopecia

25 (29)

1 (1)

26 (44)

2 (3)

52 (34)

3 (2)

Paronychia

20 (23)

6 (7)

15 (25)

2 (3)

38 (25)

10 (6)

Conjunctivitis

23 (27)

1 (1)

8 (14)

1 (2)

33 (21)

3 (2)

Dermatitis acneiform

19 (22)

5 (6)

13 (22)

3 (5)

33 (21)

8 (5)

Skin fissures

20 (23)

3 (3)

10 (17)

1 (2)

32 (21)

4 (3)

Pruritus

21 (24)

1 (1)

8 (14)

0 (0)

30 (19)

1 (1)

PPE syndrome

12 (14)

1 (1)

13 (22)

2 (3)

25 (16)

3 (2)

Skin toxicity

14 (16)

4 (5)

4 (7)

1 (2)

18 (12)

5 (3)

Erythema

10 (12)

2 (2)

4 (7)

1 (2)

16 (10)

3 (2)

  1. AE adverse event; PPE palmar-plantar erythrodysaesthesia.